Gert Storm spends much of his time researching Liposome, Pharmacology, In vivo, Targeted drug delivery and Drug delivery. His study in Liposome is interdisciplinary in nature, drawing from both Pathology, Immunology, Arthritis and Biodistribution. The concepts of his Pharmacology study are interwoven with issues in Prednisolone, Polyethylene glycol and Chemotherapy, Doxorubicin.
Gert Storm interconnects Cancer research, In vitro, Cancer cell, Biophysics and Fluorescence microscope in the investigation of issues within In vivo. The study incorporates disciplines such as Micelle, Controlled release, Receptor, Theranostic Nanomedicine and Nanomedicine in addition to Targeted drug delivery. In general Drug delivery, his work in Drug carrier is often linked to Methacrylamide linking many areas of study.
Gert Storm focuses on Liposome, Pharmacology, In vivo, Drug delivery and Cancer research. His Liposome study combines topics from a wide range of disciplines, such as Immunology, Biophysics, Drug carrier and Biodistribution. His Pharmacology research is multidisciplinary, relying on both Inflammation and Doxorubicin.
His In vivo study integrates concerns from other disciplines, such as Molecular biology, In vitro and Pathology. The Drug delivery study combines topics in areas such as Therapeutic index, Microbubbles, Micelle and Nanomedicine. His Cancer research research incorporates themes from Tumor microenvironment, Cancer, Immune system and Hepatic stellate cell.
Cancer research, In vivo, Drug delivery, Immune system and Liposome are his primary areas of study. His Cancer research research incorporates elements of Chemotherapy, Doxorubicin, Hepatic stellate cell, Tumor microenvironment and Fibrosis. As part of one scientific family, Gert Storm deals mainly with the area of In vivo, narrowing it down to issues related to the In vitro, and often Polymersome.
His work carried out in the field of Drug delivery brings together such families of science as Clinical trial, Surgery, Cataract surgery, Chemical engineering and Biomedical engineering. His research integrates issues of Cancer, Drug, Macrophage and Antigen in his study of Immune system. His biological study spans a wide range of topics, including Ex vivo, Bortezomib, Hyperthermia, Clonogenic assay and Pharmacology.
His primary areas of investigation include In vivo, Cancer research, Drug, Pharmacology and Drug delivery. Gert Storm has included themes like Pharmacokinetics, Liposome, Nuclear medicine, Vascular permeability and Noninvasive imaging in his In vivo study. Gert Storm has researched Liposome in several fields, including Proteasome inhibitor, Ex vivo, Biodistribution, Therapeutic index and Bortezomib.
His Cancer research research is multidisciplinary, incorporating perspectives in In vitro, Chemotherapy, Hepatic stellate cell, Transferrin receptor and Bone marrow. He works mostly in the field of Pharmacology, limiting it down to topics relating to Immune system and, in certain cases, Drug carrier, Chronic liver disease, Fibrosis and Macrophage. The various areas that Gert Storm examines in his Drug delivery study include Adjuvant, Thrombus, Radiology and Photothermal therapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Endosomal escape pathways for delivery of biologicals
Amir K. Varkouhi;Marije Scholte;Gert Storm;Hidde J. Haisma.
Journal of Controlled Release (2011)
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle
Raymond M. Schiffelers;Aslam Ansari;Jun Xu;Qin Zhou.
Nucleic Acids Research (2004)
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Gert Storm;Sheila O. Belliot;Toos Daemen;Danilo D. Lasic.
Advanced Drug Delivery Reviews (1995)
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
Chris Oerlemans;Wouter Bult;Mariska Bos;Gert Storm.
Pharmaceutical Research (2010)
In situ gelling hydrogels for pharmaceutical and biomedical applications.
Sophie R. Van Tomme;Gert Storm;Wim E. Hennink.
International Journal of Pharmaceutics (2008)
Tumour-targeted nanomedicines: principles and practice.
T.G.G.M. Lammers;W.E. Hennink;G. Storm.
British Journal of Cancer (2008)
Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe
Willem J. M. Mulder;Rolf Koole;Ricardo J. Brandwijk;Gert Storm.
Nano Letters (2006)
Sheddable Coatings for Long-Circulating Nanoparticles
Birgit Romberg;Wim E. Hennink;Gert Storm.
Pharmaceutical Research (2008)
Accelerated Blood Clearance and Altered Biodistribution of Repeated Injections of Sterically Stabilized Liposomes
Els T. M. Dams;Peter Laverman;Wim J. G. Oyen;Gert Storm.
Journal of Pharmacology and Experimental Therapeutics (2000)
Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times
G. Blume;G. Cevc;M.D.J.A. Crommelin;I.A.J.M. Bakker-Woudenberg.
Biochimica et Biophysica Acta (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: